Correction to: Safety and efficacy of guanfacine extended-release in adults with attention-deficit/hyperactivity disorder: an open-label, long-term, phase 3 extension study
An amendment to this paper has been published and can be accessed via the original article.
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-12-01
|
Series: | BMC Psychiatry |
Online Access: | https://doi.org/10.1186/s12888-020-02965-7 |